PlainRecalls
FDA Devices Moderate Class II Terminated

Sekisui Diagnostics Sekure Chemistry Acetaminophen L3K , Ref. 506-30. The firm names on the label are Sekisui Diagnostics (UK) Limited, United Kingdom, and Sekisui Diagnostics P.E.I. Inc., Canada. Used in laboratory testing.

Reported: September 20, 2017 Initiated: July 20, 2017 #Z-3118-2017

Product Description

Sekisui Diagnostics Sekure Chemistry Acetaminophen L3K , Ref. 506-30. The firm names on the label are Sekisui Diagnostics (UK) Limited, United Kingdom, and Sekisui Diagnostics P.E.I. Inc., Canada. Used in laboratory testing.

Reason for Recall

Reagent carryover from Sekisui ACTH when utilized on the BEC AU 680 analyzer may lead to falsely elevated BEC Lipase recovery exceeding the total precision specification.

Details

Recalling Firm
Beckman Coulter Inc.
Units Affected
320 units
Distribution
Distribution US nationwide.
Location
Brea, CA

Frequently Asked Questions

What product was recalled?
Sekisui Diagnostics Sekure Chemistry Acetaminophen L3K , Ref. 506-30. The firm names on the label are Sekisui Diagnostics (UK) Limited, United Kingdom, and Sekisui Diagnostics P.E.I. Inc., Canada. Used in laboratory testing.. Recalled by Beckman Coulter Inc.. Units affected: 320 units.
Why was this product recalled?
Reagent carryover from Sekisui ACTH when utilized on the BEC AU 680 analyzer may lead to falsely elevated BEC Lipase recovery exceeding the total precision specification.
Which agency issued this recall?
This recall was issued by the FDA Devices on September 20, 2017. Severity: Moderate. Recall number: Z-3118-2017.